PP_1170x120_10-25-21

Christian Olsen is business segment lead at Dotmatics

Pressure builds for less costly biologic development

Pressure builds for less costly biologic development

Biologic drugs have increasingly delivered treatments for cancer and rare diseases and continue to prove effective in other wide-ranging areas, from neurological and metabolic disorders to respiratory and cardiovascular diseases. But along with the incredible potential biologics offer, there is also great pressure to discover and deliver novel treatments quickly and cost effectively. Biologics represent

Adheris Health